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Human notochordal cell 
transcriptome unveils potential 
regulators of cell function in the 
developing intervertebral disc
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Andrew Berry5, Karen Piper Hanley  5, Neil Hanley  5,6,7, Stephen M. Richardson  1 & 
Judith A. Hoyland  1,7
The adult nucleus pulposus originates from the embryonic notochord, but loss of notochordal cells with 
skeletal maturity in humans is thought to contribute to the onset of intervertebral disc degeneration. 
Thus, defining the phenotype of human embryonic/fetal notochordal cells is essential for understanding 
their roles and for development of novel therapies. However, a detailed transcriptomic profiling of 
human notochordal cells has never been achieved. In this study, the notochord-specific marker CD24 
was used to specifically label and isolate (using FACS) notochordal cells from human embryonic and 
fetal spines (7.5–14 weeks post-conception). Microarray analysis and qPCR validation identified CD24, 
STMN2, RTN1, PRPH, CXCL12, IGF1, MAP1B, ISL1, CLDN1 and THBS2 as notochord-specific markers. 
Expression of these markers was confirmed in nucleus pulposus cells from aged and degenerate discs. 
Ingenuity pathway analysis revealed molecules involved in inhibition of vascularisation (WISP2, Noggin 
and EDN2) and inflammation (IL1-RN) to be master regulators of notochordal genes. Importantly, this 
study has, for the first time, defined the human notochordal cell transcriptome and suggests inhibition 
of inflammation and vascularisation may be key roles for notochordal cells during intervertebral disc 
development. The molecules and pathways identified in this study have potential for use in developing 
strategies to retard/prevent disc degeneration, or regenerate tissue.
Degeneration of the intervertebral disc (IVD) is associated with the development of low back and neck pain1, 
which are highly debilitating symptoms affecting up to 80% of the world population2. While current conservative 
and surgical therapies are relatively effective in relieving pain short term, they are not devoid of complications3,4 
and fail to inhibit the degenerative process or promote repair. As such there is a need to develop alternative ther-
apies that target the underlying aberrant molecular and cell biology.
However, to enable the development of novel biological or cell-based therapies for disc degeneration it is 
essential to characterise the pathways and processes involved in IVD development, maturation and degeneration. 
While in the embryonic, fetal and juvenile human IVD the nucleus pulposus (NP) is populated by large vacu-
olated notochordal cells, the adult disc is populated by small non-vacuolated chondrocyte-like cells (reviewed 
in5). Through study of animal tissue, notochordal cells have been proposed to play a fundamental role in IVD 
1Division of Cell Matrix Biology and Regenerative Medicine, School of Biological Sciences, Faculty of Biology, 
Medicine and Health, The University of Manchester, Stopford Building, Oxford Road, Manchester, M13 9PT, United 
Kingdom. 2Spinal Unit, Department of Orthopaedics, Centro Hospitalar do Porto – Hospital de Santo António, Largo 
Prof. Abel Salazar, 4099-001, Porto, Portugal. 3ICBAS - Instituto de Ciências Biomédicas Abel Salazar, Rua de Jorge 
Viterbo Ferreira n° 228, 4050-313, Porto, Portugal. 4Faculty of Biology, Medicine & Health, University of Manchester, 
Oxford Road, Manchester, M13 9PT, UK. 5Division of Diabetes, Endocrinology & Gastroenterology, School of Medical 
Sciences, Faculty of Biology, Medicine & Health, University of Manchester, Oxford Road, Manchester, M13 9PT, UK. 
6Research & Innovation, Manchester University NHS Foundation Trust, Grafton Street, Manchester, M13 9WU, UK. 
7NIHR Manchester Biomedical Research Centre, Central Manchester Foundation Trust, Manchester Academic Health 
Science Centre, Manchester, United Kingdom. Correspondence and requests for materials should be addressed to 
S.M.R. (email: s.richardson@manchester.ac.uk) or J.A.H. (email: judith.a.hoyland@manchester.ac.uk)
Received: 9 February 2018
Accepted: 1 August 2018
Published: xx xx xxxx
OPEN
www.nature.com/scientificreports/
2SCientiFiC RePoRts |  (2018) 8:12866  | DOI:10.1038/s41598-018-31172-4
homeostasis6–9 and their loss with maturity in humans has been suggested to contribute to onset of the degener-
ative process10.
Thus, understanding the phenotype of notochordal cells and their potential regulatory molecules will help 
identify factors important in maintaining healthy disc homeostasis which may be exploited in the development 
of novel biological/regenerative therapies. Furthermore, the identification of human notochord-specific mark-
ers will further our understanding of whether notochord-derived cells persist in the adult NP. However, while 
studies have been undertaken using animal models11–18, to date the human notochordal cell phenotype has not 
been characterised in detail and this lack of understanding of human notochordal cell phenotype and biology is 
a major limitation in the field.
In a pivotal study using human embryonic and fetal spines, we have recently shown that the developing NP is 
composed of large vacuolated notochordal cells and that keratin (KRT) 8, KRT18, KRT19 are uniquely expressed 
by notochordal cells at all spine levels investigated at all stages studied (Carnegie Stage 10 (equivalent to 3.5 weeks 
post-conception (WPC)) to 18 WPC), with CD24 also being uniquely expressed at all stages except 3.5 WPC19.
The unique expression of these markers makes them suitable for use in identification and isolation of notochordal 
cells from human embryos and foetuses and specifically CD24, being a cell-surface marker, allows for the isola-
tion of viable notochordal cells.
Thus the hypotheses for this study were that: (i) the human developing NP contains notochordal cells which 
can be isolated from their adjacent sclerotomal cells by the unique expression of CD24; (ii) isolation of human 
notochordal cells will allow a characterisation of their phenotype and regulatory networks, upstream regulators 
and downstream functions allowing a better understanding of their function and role in the developing IVD and 
in protecting the IVD from degeneration and; (iii) the human adult NP contains cells that express notochordal 
cell markers, suggesting a persistence of notochordal cells in the human adult NP. As such, the aims of this study 
were to: (i) isolate viable notochordal cells from surrounding sclerotomal tissues of the human fetal spines; (ii) 
characterise the transcriptome of human notochordal cells and their potential regulatory networks and pathways; 
and (iii) assess whether notochord-derived cells are present in the human adult NP.
Results
Separation of CD24+ and CD24− spine cells and qPCR validation of cell separation. 
Immunostaining of human developing spines confirmed discrete expression of CD24 within only large vacuo-
lated notochordal cells of the developing NP, as previously described19 (Fig. 1A). FACS analysis of human spine 
cells isolated from developing spines identified a small viable population (5.0–19.5%) of CD24+ cells within a 
larger viable population (42.1–89.9%) of CD24− cells (Fig. 1B,C; Supplementary Figure 1). qPCR revealed sig-
nificantly higher CD24, KRT19, CDH2, NOG and T gene expression in CD24+ than in CD24− cells, confirming 
separation of CD24+ notochordal cells from CD24− sclerotomal cells (Fig. 1D).
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Figure 1. Isolation of viable human CD24+ (notochordal) cells and CD24− (sclerotomal) cells from fetal 
human spines. (A) CD24 immunostaining of an 8 WPC human fetal spine showing notochord-specific 
staining. (B) FACS plot of the 12 WPC specimen used in the microarray analysis showing CD24-PE positivity 
against side scatter-height (SSC-H). P4 represents viable CD24+ events and P5 represents viable CD24− events. 
(C) Proportion of viable CD24+ and CD24− events sorted from each sample and predicted sex (based on 
transcriptome analysis) of each sample. (D) Relative gene expression of CD24, T, CDH2, Noggin, KRT8, KRT18 
and KRT19 in CD24+ and CD24− cells used in microarray analyses (N = 5). Gene expression was normalised 
to the reference gene GAPDH and then CD24+ cell expression was plotted relative to the expression in CD24− 
cells and presented on a log scale. Error bars represent the standard error of the mean of the samples analysed.  
* represents p < 0.05.
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Identification of CD24+ and CD24− markers using microarrays. Three CD24− samples failed to pass 
microarray quality control criteria and were excluded from further analysis. As such, microarray analysis was 
performed by comparing the expression of CD24+ samples from 5 and CD24− samples from 2 specimens. PCA 
analysis demonstrated that the genes from CD24+ cells clustered together and away from those of CD24− cells 
(Fig. 2A). A differential expression test performed using a log ratio >2 or <2 and a p value ≤ 0.05 identified 884 
up-regulated and 1460 down-regulated genes in CD24+ cells relative to CD24− cells (Fig. 2B). Hierarchical clus-
tering showed segregation between CD24+ and CD24− differentially expressed genes, with a similar gene expres-
sion profile between the cells from the 5 CD24+ samples, which differed substantially from that of the cells from 
the 2 CD24− samples (Fig. 2C). Together, these results indicate that the gene expression profile of CD24+ cells is 
distinct from that of CD24− cells, demonstrating a clear separation between cell types.
Top notochordal markers were CD24, STMN2, RTN1, PRPH, CXCL12, IGF1, MAP1B, ISL1, CLDN1 and 
THBS2 and top sclerotomal markers were WISP3, CHST11, SERPINA3, CHAD, ZNF385B, LIF, PLA2G2A, 
PRSS33, FOSL1 and COL11A2 (Table 1).
Validation of identified markers using qPCR. Differential expression of the top 10 CD24+ and top 4 
CD24− (bottom CD24+) differentially expressed genes was validated using qPCR, which revealed that all CD24+ 
markers CD24, STMN2, RTN1, PRPH, CXCL12, IGF1, MAP1B, ISL1, CLDN1 and THBS2 had significantly 
higher expression in CD24+ than in CD24− cells (Fig. 3A). Similarly, the CD24− markers WISP3, CHST11, 
SERPINA3 and CHAD had lower expression in CD24+ than in CD24− cells (Fig. 3B); this difference was statisti-
cally significant for all markers except for CHST11.
To exclude the fact that concordant results between the microarray analysis and qPCR could be inherent to the 
biology of samples used in the microarrays, the expression of the same genes was analysed in RNA from CD24+ 
and CD24− cell samples isolated from two additional specimens of similar ages (9 and 11 WPC). qPCR demon-
strated that the expression patterns for top 10 CD24+ (Fig. 3C) and top 4 CD24− markers (Fig. 3D) was similar to 
that seen in samples used in the microarray analysis (Fig. 3A,B respectively).
Expression of notochordal markers in human adult NP samples. To investigate the expression of 
notochordal cell markers in the adult NP and how expression differed from levels seen in fetal CD24+ noto-
chordal cells, the expression of CD24, STMN2, RTN1, PRPH, CXCL12, IGF1, MAP1B, ISL1, CLDN1 and THBS2 
was analysed in CD24+ sorted notochordal cells and NP cells isolated from adult tissue using qPCR. Importantly 
all notochordal markers were expressed in the NP of the cohort analysed (Fig. 4). Expression of CD24, STMN2, 
RTN1, PRPH, IGF1, MAP1B, ISL1, CLDN1 and THBS2 were all significantly lower in NP cells compared to 
notochordal cells, while expression of MAP1B was significantly increased in adult NP cells compared to fetal 
CD24+ notochordal cells.
Expression of the novel notochordal marker genes was also investigated in the adult NP cell cohort to deter-
mine whether their expression varied with different ages or stages of degeneration. No clear correlation was iden-
tified for the majority of the genes with ageing (Supplementary Figure 2) or with degeneration (Supplementary 
Figure 3); with only MAP1B showing a significant correlation with age or degeneration.
Gene pathway analysis. To identify the networks, master regulators and biological functions of noto-
chordal cells, dataset molecules (differentially expressed genes with −2 < FC < 2, p < 0.05) were subjected to 
IPA® analysis.
Within the top networks identified, those with highest known physiological relevance were: (i) connective 
tissue development and function (Supplementary Figure 4), (ii) nervous system development and function and 
(iii) development, skeletal and muscular disorders (Supplementary Table 3).
To identify which molecules regulate notochordal gene expression, master regulators were analysed. The list 
of master regulators was filtered to identify those which had a predictable activation state and that were either 
growth factors or cytokines (Table 2). These specific regulators were selected to better understand the specific 
microenvironment in which notochordal cells reside and which may thus control their function, and to identify 
potential factors which could drive stem/progenitor cell differentiation to notochordal cells. WNT1-inducible 
signalling pathway (WISP2), noggin and endothelin-2 (EDN2) were the growth factors predicted to be active 
master regulators of notochordal cell gene expression. IL-1 receptor antagonist (IL1RN), IL37 and sprouty-related 
EVH1 domain containing 2 (SPRED2) were the cytokines that were predicted to be active master regulators of 
notochordal cell gene expression. Noggin and IL-1RN were found to be upstream and may explain 13 and 19 
up or downregulated dataset molecules respectively (Fig. 5). VEGFA and TGFβ1 were within the list of growth 
factors predicted to be inhibited and IL-2, TNF, IL-5 and IL-20 were within the list of cytokines predicted to be 
inhibited (Table 2).
To understand which diseases or functions may be affected by the genes in the dataset, top diseases and func-
tions were analysed; only those with a predictable activated state (z score <2 for inhibition and >2 for activation) 
were considered. There were 503 dataset molecules associated with organism survival, and this function was pre-
dicted to be active. Within the top functions predicted to be inhibited downstream of the dataset molecules were 
development of blood vessels, vasculogenesis and angiogenesis (Table 3).
Discussion
While several studies have attempted to characterise the phenotype of notochordal cells in animal models11–18, 
results from these studies may not be directly translatable to human research as the NP cell (which derives 
from the notochordal cell) phenotype varies considerably between species13,20,21. Here, for the first time human 
notochordal cells were isolated and their phenotype characterised and validated at the transcriptome level. The 
findings presented confirm the robustness of our novel methodology to isolate human notochordal cells from 
www.nature.com/scientificreports/
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Figure 2. Bioinformatics analysis of microarray data. (A) Principal component analysis of the genes expressed 
by CD24+ (blue) and CD24− (purple) cells. As CD24+ genes clustered in close proximity to each other and 
distant to CD24− genes, this indicated a clear separation between two different cell types with a distinct gene 
expression. (B) Volcano plot depicting the differential gene expression signals between CD24+ and CD24− 
genes. Only genes with a fold change <−2 or >2 and with a p-value < 0.05 were considered to be differentially 
expressed and were used for further analysis. (C) Hierarchical clustering of the genes in the 5 CD24+ 
(notochordal) and 2 CD24− (sclerotomal) samples analysed. Each column represents one sample and each 
line represents one gene. Boxes in red indicate upregulation and boxes in green indicate downregulation. The 
dendogram identifies two main groups corresponding to CD24+ and CD24− genes.
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sclerotomal cells using the recently identified specific human notochordal marker CD2419. Importantly our new 
methodology adds substantial novelty to the field as it can potentially be reproduced to isolate viable human 
notochord cells which can be used in in vitro experiments to better elucidate their function.
The CD24+ notochordal cells were shown to express a panel of known notochordal marker genes including 
T, CDH2, NOG, KRT8, 18 and 19, with the majority of genes showing significant differential expression between 
CD24+ notochordal cells and CD24− sclerotomal cells. Interestingly, KRT8 and 18 did not show differential 
expression, conflicting with our earlier study demonstrating notochord-specific expression at protein level at the 
fetal stages studied here19. Regulation of keratin expression in other tissues, such as skin, has been shown to be 
complex and includes post-transcriptional regulation22. Such post-transcriptional regulation can vary according 
to cell type, local environmental factors, response to injury and age, and in the IVD differences between keratin 
gene and protein expression have been described with ageing23. Similar post-transcriptional regulation mecha-
nisms may occur developmentally explaining differences observed between expression of keratins at gene and 
protein level in the human fetal notochordal and sclerotomal cells studied here.
Significantly, the notochordal markers identified here provide the first transcriptomic characterisation of 
human notochordal cells, and highlight genes that are relevant to the IVD physiology and homeostasis, some of 
which have already been proposed as biomarkers of a healthy IVD. Further investigations into the role of these 
genes in the adult normal and degenerate IVD may highlight their relevance in this tissue. Interestingly, and 
confirming the importance of analysing human tissue, although some of these markers have been linked to func-
tions that may be relevant to their role in the IVD, from all the markers identified in this analysis, only CD24 had 
previously been associated with the notochord or with the notochordal rich NP24.
From the top notochordal cell markers identified here only IGF-1, CLDN1 and THBS2 have previously been 
associated with the IVD. IGF-1 has been suggested to play a fundamental role in rat, bovine and human NP cell 
proliferation, anabolism and homeostasis25–28 and IGF-1, along with other family members, have recently been 
identified in a transcriptomic profiling of mouse notochordal cells15. CLDN1 has also been previously identified 
in the IVD29. CLDN1 is involved in cell polarity in epithelial cells and its expression by notochordal cells may 
be explained by the fact that these cells also display epithelioid characteristics such as cell polarity and cell-cell 
contact30, which are lost with skeletal maturity. THBS2 is an IVD extracellular matrix protein regulating the levels 
of the catabolic proteins MMP2 and MMP931,32. It has been hypothesised to be important for the maintenance 
of the avascular state of the human and sand rat IVD33 and the THBS2 rs9406328 polymorphism is associated 
with disc herniation34. THBS2 expression by notochordal cells further emphasises the importance of these cells 
in maintaining IVD homeostasis. While the other top markers identified from our study have been linked with 
functions such as embryogenesis, nervous system development, epithelial cell proliferation, cell adhesion and 
insulin regulation, it is unclear if these genes perform similar functions in human spine development.
Importantly all the top notochordal markers were expressed to different degrees in the adult NP and no cor-
relation was identified with ageing or histological grade of degeneration. This extends our recently published 
data which demonstrated that the gene and protein expression of known notochordal markers did not vary 
Symbol Gene name Fold Change Log Ratio p-value
Notochordal Genes (Upregulated in CD24+ Cells)
CD24 CD24 molecule 68.102 6.090 1.29 × 10−06
STMN2 stathmin-like 2 48.064 5.587 2.34 × 10−02
RTN1 reticulon 1 45.294 5.501 2.25 × 10−03
PRPH peripherin 45.207 5.498 2.62 × 10−04
CXCL12 chemokine (C-X-C motif) ligand 12 33.187 5.053 1.51 × 10−03
IGF1 insulin-like growth factor 1 (somatomedin C) 28.073 4.811 4.65 × 10−04
MAP1B microtubule-associated protein 1B 22.298 4.479 4.32 × 10−04
ISL1 ISL LIM homeobox 1 21.659 4.437 3.40 × 10−02
CLDN1 claudin 1 21.351 4.416 1.64 × 10−05
THBS2 thrombospondin 2 19.325 4.272 3.86 × 10−03
Sclerotomal Genes (Downregulated in CD24+ Cells)
WISP3 WNT1 inducible signaling pathway protein 3 −26.830 −4.746 1.41 × 10−04
CHST11 carbohydrate (chondroitin 4) sulfotransferase 11 −26.430 −4.724 5.69 × 10−04
SERPINA3 serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 −24.647 −4.623 1.27 × 10
−03
CHAD chondroadherin −21.463 −4.424 2.44 × 10−03
ZNF385B zinc finger protein 385B −20.667 −4.369 2.33 × 10−04
LIF leukemia inhibitory factor −20.373 −4.349 8.86 × 10−04
PLA2G2A phospholipase A2, group IIA (platelets, synovial fluid) −18.677 −4.223 1.58 × 10−03
PRSS33 protease, serine, 33 −17.432 −4.124 9.16 × 10−03
FOSL1 FOS-like antigen 1 −16.776 −4.068 5.05 × 10−02
COL11A2 collagen, type XI, alpha 2 −16.233 −4.021 5.44 × 10−03
Table 1. Top (notochordal) and bottom (sclerotomal) differentially expressed genes between CD24+ and 
CD24− cells identified from Affymetrix microarray analysis.
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with ageing or degeneration across a wide range of adult NP tissues35. The current data adds further evidence 
to the theory that notochordally-derived cells are indeed present in the adult human NP, as has been previously 
suggested13,18,35,36.
It has been suggested that notochordal cells may exert their protective and anabolic role due to soluble fac-
tors secreted by them37,38, particularly inflammatory mediators, anabolic factors such as CTGF and TGFβ1, and 
anti-angiogenic factors9,39 and this has been shown in vitro to be potentiated in hypoxic cultures40. However, these 
findings all derive from studies in animals and may not be directly translatable to human biology. As such, in this 
study, IPA was utilised to identify biological networks, master regulators and potential downstream functions of 
human notochordal cells.
The top biological networks associated with notochordal cells were “connective tissue development and 
function” and “nervous system development and function” possibly reflecting two of the main functions of the 
developing notochord: providing structural support and induction of the development of the neural tube41,42. 
Furthermore, notochordal signalling (particularly through Shh, Wnt and BMP) is fundamental for neural tube 
patterning, differentiation and development41,43–45.
When analysing master regulators of notochordal cell genes, three “growth factors” were predicted to be 
active: WISP2, NOG and EDN2. WISP2 (CCN5) is a member of the CTGF/CCN family of secreted, extracellular 
matrix-associated proteins46 that has been shown to be an inhibitor of angiogenesis47. Furthermore, this molecule 
has recently been identified in non-chondrodystrophic dog notochordal cell conditioned medium (together with 
TGFbeta1 and CTGF) and proposed to be important for the homeostatic regulation of the healthy NP39. Noggin 
is a BMP antagonist that is produced by the notochord and that is involved in somite patterning48 together with 
maintenance of an avascular state in the embryo’s midline. It has been previously shown that Noggin, together 
with chondroitin sulphate, are notochordal soluble factors responsible for inhibiting endothelial cell invasion and 
blood vessel formation in the IVD49. More recently, in a transcriptomic study of mouse notochord-derived cells, 
Peck and colleagues identified that expression of Noggin was significantly higher at embryonic stage 12.5 than 
at birth (P0) suggesting its role in early spine development15. While no studies have linked EDN2 to notochordal 
cell biology, it has been identified as a potent angiogenic inhibitor in the developing retina50. These three master 
regulators of notochordal cells have a common aspect, which is relevant to notochordal cell biology and, possibly 
to the notochordal cell role in protecting against IVD degeneration, i.e. they all inhibit angiogenesis. Interestingly, 
VEGFA was among the growth factor master regulators predicted to be inhibited, again suggesting that noto-
chordal cell function is widely regulated by anti-angiogenic mechanisms.
Further highlighting the relevance of inhibition of angiogenesis as a key role of notochordal cells, IPA analysis 
of downstream functions, i.e. functions regulated by notochordal cells, identified several angiogenic functions 
(development of blood vessels, vasculogenesis and angiogenesis) and all were predicted to be inhibited down-
stream of notochordal cells. This anti-angiogenic function is key to notochordal cell biology, as one of the main 
functions attributed to the notochord during development is the maintenance of an avascular midline region 
in the embryonic tissue51. The negative regulatory function has been suggested to be induced by Noggin and 
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Figure 3. qPCR validation of differential gene expression. Relative expression of novel positive (A,C) and 
negative (B,D) notochordal marker genes in CD24+ (notochordal) cells relative to CD24− (sclerotomal) cells 
isolated from the same human embryonic and fetal specimens used in the microarray analysis (A,B) and two 
additional specimens (9 and 11 WPC) (C,D). Gene expression was normalised to the reference gene GAPDH 
and the mean CD24+ cell expression was plotted relative to the mean expression in CD24− cells and presented 
on a log scale. N = 5 for CD24+ and N = 2 for CD24− samples in panels A and B; N = 2 for both CD24+ and 
CD24− samples in panels C and D. Error bars represent the standard error of the mean of the samples analysed. 
* represents p < 0.05.
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Chordin (BMP antagonists) suppression of endothelial cell differentiation and maturation49,52. This avascular, and 
also aneural, state of the midline is seen in the fully matured healthy IVD. Conversely, degeneration of the IVD 
coincides with the migration of neo-nerve and -vessels to the IVD1. Crucially these data suggest that notochordal 
cells are responsible for inhibition of angiogenesis in the developing and, possibly, in the non-degenerate NP and 
that, with notochordal cell disappearance or loss of function, the loss of this inhibition may be important in the 
genesis of IVD degeneration.
Within the master regulators of notochordal cell gene expression, the pro-inflammatory cytokines IL-2 TNF, 
TNFSF13B, IL-5 and IL-20 were predicted to be inhibited and IL-1RN was predicted to be activate upstream of noto-
chordal cell genes. The role of pro-inflammatory cytokines in IVD degeneration has been extensively studied, with their 
expression being upregulated in degenerated discs53,54 and an imbalance between IL-1ß and its inhibitor (IL-1RN) has 
been shown to be involved in the pathogenesis of IVD degeneration with the authors proposing IL-1RN as a poten-
tial therapy for disc degeneration53,55. Further emphasising the importance of IL-1RN in maintaining a healthy IVD, 
Phillips and colleagues56 have shown that IL-1RN null mice display typical features of IVD degeneration. Thus, since the 
loss of IL-1RN may be one of the key drivers of IVD degeneration, it is possible that the loss of this notochordal-driven 
anti-inflammatory role is involved in the protective role notochordal cells exert in the IVD.
To conclude this is the first study to isolate and phenotype human notochordal cells. Significantly this provides 
fundamental tools to isolate viable human notochordal cells for future culture studies and phenotypic markers 
to define the phenotype of native/cultured notochordal cells or differentiated stem/progenitor cells. Importantly, 
this study also supports our recent work demonstrating that sub-populations of notochordal cells persist in the 
adult NP35; however, the role of these notochord-derived cells in the adult NP remains to be elucidated. Finally, 
this seminal study unveils the networks, regulators and downstream functions of human notochordal cells and 
identifies inhibition of inflammation and of angiogenesis among the most relevant notochordal functions during 
IVD development and maturation. We postulate that strategies aimed at inhibiting inflammation and angiogene-
sis, or in elucidating the roles of master regulators in the developing and adult IVD, should be investigated as their 
regulation can potentially retard or even prevent IVD degeneration.
Methods
Embryonic and fetal samples. Sample acquisition and processing. Embryonic and fetal samples (n = 7) 
were obtained with ethical approval from the local research ethics committee (Manchester Royal Infirmary, Ref. 
No: 08/H1010/28 Early Pregnancy Tissue Collection) and with fully informed written consent following medi-
cal or surgical pregnancy termination. All experimental protocols were performed in accordance with National 
Research Ethics Service and University of Manchester guidelines and regulations. Embryonic staging was per-
formed according to the Carnegie classification57 and converted to WPC. Fetal staging was estimated by hand 
and foot length measurements and spine development macroscopically resembled previously described mor-
phology19. Samples were processed within 2–4 hours of acquisition and the whole spine containing the verte-
brae and IVDs was dissected from its adjacent tissues under sterile conditions, using microsurgical instruments 
and a stereomicroscope (Stem 2000, Carl Zeiss®), as previously described19. A 5 µm section of formalin-fixed 
paraffin embedded tissue from fetal samples at the WPC stages used for dissection were subjected to CD24 
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Figure 4. Comparison of expression of novel notochordal cell marker genes by human fetal notochordal cells 
and adult human NP cells. Box and whisker plots depicting the relative gene expression of CD24, STMN2, 
RTN1, PRPH, CXCL12. IGF1, MAP1B, ISL1 and CLDN1 in CD24+ (notochordal) cells (N = 5) and adult 
human NP cells (N = 17). Gene expression values were normalised to the reference gene GAPDH and plotted 
on a log scale. Graphs depict median, interquartile range and minimum/maximum values, with mean annotated 
as +. * represents p < 0.05.
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immunostaining as previously described19. Sex of samples was determined retrospectively through analysis of 
expression levels of a panel of previously identified female (XIST) and male (KDM5D, DDX3Y and RPS4Y1) 
transcript biomarkers in the microarray datasets58 (Supplementary Figure 5).
Isolation of notochordal and sclerotomal cells. Following dissection, spines were cut into small fragments and 
digested for 2 hours in medium (alpha-MEM (Sigma-Aldrich®, M4526)) containing 1% (v/v) antibiotic/ anti-
mycotic solution and 0.1% (w/v) type II collagenase (Gibco®, 17101-015) in an orbital shaker at 37 °C; cell clus-
ters were subsequently dissociated by incubation for 10 minutes at 37 °C in cell dissociation solution (Sigma®, 
C1419). Cells were washed twice in FACS buffer (0.5% BSA in 2 mM EDTA (Sigma-Aldrich®, T4174) in PBS, 
sieved through a 40 µm cell filter, and labelled with 0.3 μM Draq7® and 0.5 μg/mL of PE-conjugated anti-CD24 
antibody (Beckman Coulter®, Cat: PN IM1428U) in FACS buffer for 10 minutes in the dark, at 4 °C. Samples 
were then washed FACS buffer, re-suspended in ice-cold PBS and immediately used for FACS (FACS Aria II; BD 
Biosciences). An isotype control (0.2 μg/mL IgG1, BD Pharminogen®, 550617) and Draq7® viability dye (0.3 μM) 
were used to establish gates for viable CD24+ and CD24− cells. Viable CD24+ and CD24− cells were sorted sep-
arately into microcentrifuge tubes containing 350 μL of RLT lysis buffer (RNeasy micro plus kit, Qiagen®) and 
RNA extracted immediately. No differences were detected in the forward and side scatter distribution of CD24+ 
and CD24− events within each sample.
RNA extraction and amplification. RNA from embryonic and fetal spines was obtained using the RNeasy micro 
plus kit (Qiagen®, 74034). The following changes were made to the manufacturer’s protocol: (i) cell lysate was 
warmed to 37 °C before homogenisation; (ii) to elute the RNA from the column, water was warmed to 60 °C; and 
(iii) to allow for higher RNA recovery, the final eluent was re-pipetted through the column.
Due to the small amount of RNA obtained (inherent to the small specimen size), RNA was amplified to 
Spia® (Single Primer Isothermal Amplification) cDNA using the Ovation Pico WTA v2 kit (CAT NuGen 
Technologies®, 3302), purified using the RNeasy MinElute kit (Qiagen®, 74204). All steps were performed 
Master Regulator Activation z-score Log Ratio p-value of overlap
Growth factors predicted to be active
WISP2 3.253 −0.143 2.12E-24
NOG 3.103 −2.306 1.19E-14
EDN2 2.142 0.059 5.24E-08
Cytokines predicted to be active
IL1RN 5.317 1.530 1.59E-22
IL37 4.730 0.068 2.05E-21
SPRED2 2.209 −0.888 3.77E-13
Growth factors predicted to be inhibited
BDNF −4.507 0.930 2.73E-22
NRG1 −4.415 1.170 1.64E-28
CLEC11A −4.320 −0.498 8.39E-17
VEGFA −3.967 −1.631 3.49E-24
IGF1 −3.768 4.811 1.32E-27
TGFB1 −3.762 −0.700 6.41E-17
EGF −3.755 0.503 2.79E-11
GRP −3.530 0.034 1.21E-22
JAG1 −3.516 1.344 9.11E-25
FGF1 −3.316 −0.513 1.60E-25
Cytokines predicted to be inhibited
IL2 −5.607 0.510 5.71E-23
OSM −5.088 −0.131 4.76E-20
CCL5 −4.899 0.207 2.36E-20
TNF −4.807 0.425 4.55E-21
TNFSF13B −4.741 0.236 5.89E-17
CXCL12 −4.434 5.053 8.25E-27
TRIP6 −4.426 −0.882 6.35E-12
VAV3 −4.330 1.178 8.42E-17
IL5 −4.202 0.046 2.08E-09
IL20 −4.122 −0.199 5.84E-20
Table 2. Master regulators of differentially expressed genes. Log2 ratio represents differential expression of 
the regulator in the dataset; activation z-score represents the activation state (inhibited if <−2 and active if 
>2), and p-values represent the likelihood of the regulator regulating the genes in the dataset not being due to 
chance.
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according to manufacturer’s instructions. RNA integrity was analysed using the Agilent 2100 Bioanalyser (Agilent 
Technologies®). Only high quality RNA (RNA integrity number >7) was used for microarrays.
Validation of the cell separation method. Before undertaking microarray analysis and to confirm that the sorted 
cells were notochordal and sclerotomal, real-time quantitative PCR (qPCR) for the genes CD24, CDH2, T, 
KRT8, KRT18, KRT19, Noggin was performed using TaqMan Universal PCR Master Mix (Applied Biosystems®, 
4304437) and gene expression levels compared between CD24+ and CD24− viable sorted cells, as previously 
described13,20.
cDNA microarrays. RNA was fragmented and labelled using the Encore Biotin Module (NuGen Technologies®, 
4200), according to manufacturer protocol.
Four micrograms of SPIA® cDNA from each sample was hybridized to the GeneChip human genome U133 
Plus 2.0 array (Affymetrix®, 900466), according to manufacturer’s instructions. Technical quality control was 
performed with dChip software59; an array was considered to be an outlier when more than 5% of the probe sets 
for that array were judged as outliers by the dChip outlier detection algorithm. Background correction, quantile 
normalization, and gene expression analysis were performed using the robust multiarray average (RMA) analysis 
in the Bioconductor software package60. Differential expression analysis was performed using routine analytical 
methods (Smyth, 2004). Lists of differentially expressed genes were controlled for false discovery rate (FDR) 
errors using the QValue method61.
Microarray analysis. Differentially expressed genes were defined as those with an FDR-corrected P value (called 
the q value) of ≤0.05 and a minimum normalized expression level of ≥2 fold. CD24+ marker genes were those 
with the highest differential expression between CD24+ and CD24− cells and CD24− marker genes were those 
with the highest differential expression between CD24− and CD24+ cells.
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Figure 5. Predicted interactions between the growth factors (A) IL1RN, and (B) Noggin (NOG) and dataset 
genes generated through the use of IPA (QIAGEN Inc., www.qiagenbioinformatics.com/products/ingenuity-
pathway-analysis/)62.
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Hierarchical clustering, principal component analysis (PCA) and volcano plots were analysed using Partek 
Genomics Suite (Partek Inc®, St. Louis, MO, USA).
Ingenuity® Pathway Analysis Software (IPA) (QIAGEN Inc., www.qiagenbioinformatics.com/products/
ingenuity-pathway-analysis/)62 was used to identify networks, master regulators and biological functions of dif-
ferentially expressed genes. p-values were calculated using the right-tailed Fisher Exact Test; Benjamini-Hochberg 
test was used for p-value multiple testing correction.
IPA analyses performed were: IPA Network Analysis, IPA Functions and IPA Master Regulators. IPA Network 
Analysis identifies regulatory networks (protein-protein interactions) between genes in a dataset to help under-
stand how those genes are biologically related. IPA Functions analyses biological functions and disease processes 
relevant to the dataset genes and predicts their activation state (active or inhibited), which is given by the z-score. 
z-scores greater than 2 (active) or smaller than −2 (inhibited) were considered significant. Master regulators are 
molecules that can affect the expression of regulators of the molecules in the dataset and can also be predicted to 
be active (positive master regulators) or inhibited (negative master regulators) and this information is given by 
the z score. The list of regulators was filtered to identify those with a predictable activation state (z-scores greater 
than 2 or smaller than −2) and that were either cytokines or growth factors.
qPCR validation of differentially expressed genes. After performing the microarrays, expression of the newly 
identified differentially expressed genes was analysed in CD24+ and CD24− sorted cells using SYBR green63. In 
addition to confirming differential expression in samples used in the microarray analysis, expression was also 
assessed in CD24+ and CD24− sorted cells from two additional developing spines (9 and 11 WPC). Pre-optimised 
SYBR green primers were purchased from PrimerDesign (Southampton, UK). The expression of each gene was 
normalised to the most stable reference gene (Glyceraldehyde 3-phosphate dehydrogenase (GAPDH)) and 
data was analysed using the previously described 2−ΔCt and 2−ΔΔCt methods64,65. PCR primers are detailed in 
Supplementary Table 1.
Analysis of Novel Notochordal Cell Gene Expression in Adult NP samples. Adult IVD tissue was obtained at the 
time of surgery from 17 patients with disc degeneration (diagnosed by magnetic resonance imaging) who under-
went disc replacement or spinal fusion (Supplementary Table 2). Written informed consent was obtained from 
all patients and the study was approved by the local research ethics committee. NP tissues were dissected from 
surgical samples, grade of degeneration classified histologically using a previously published grading system66 
and cells were extracted as previously reported67. RNA was extracted using TRIzol and reverse transcribed to 
cDNA using a high capacity cDNA reverse transcription kit with RNase inhibitor (Thermo Life Technologies), as 
previously described13,20, then gene expression analysed as described above.
Categories
Diseases or functions 
annotation p-Value
Predicted 
activation state
Activation 
z-score
Number of 
dataset molecules
Cellular Growth and Proliferation proliferation of cells 1.39E-28 Decreased −2.299 733
Cellular Movement cell movement 2.35E-23 Decreased −2.647 446
Cellular Movement migration of cells 3.63E-22 Decreased −2.479 405
Organismal Survival organismal death 7.25E-21 Increased 3.156 503
Cancer malignant neoplasm of abdomen 2.84E-18 Decreased −2.558 812
Gene Expression expression of RNA 1.47E-16 Decreased −3.309 422
Cardiovascular System Development 
and Function
development of cardiovascular 
system 1.06E-15 Decreased −2.709 238
Cardiovascular System Development 
and Function, Organismal Development development of blood vessel 1.89E-15 Decreased −2.704 194
Gene Expression transcription 3.60E-15 Decreased −3.354 379
Gene Expression transcription of RNA 3.99E-15 Decreased −3.294 373
Cardiovascular System Development 
and Function, Organismal Development vasculogenesis 5.18E-15 Decreased −2.652 176
Gene Expression transcription of DNA 1.68E-13 Decreased −2.011 298
Cellular Movement cell movement of tumor cell lines 3.25E-13 Decreased −2.189 183
Cellular Movement migration of tumor cell lines 2.40E-12 Decreased −2.058 151
Cardiovascular System Development 
and Function angiogenesis 5.63E-12 Decreased −2.624 160
Developmental Disorder, Skeletal and 
Muscular Disorders
congenital anomaly of 
musculoskeletal system 5.18E-11 Increased 2.298 147
Cardiovascular System Development 
and Function, Cellular Movement
cell movement of endothelial 
cells 6.18E-11 Decreased −2.067 91
Cardiovascular System Development 
and Function, Tissue Development
development of cardiovascular 
tissue 6.31E-11 Decreased −2.013 103
Cellular Growth and Proliferation proliferation of epithelial cells 2.19E-10 Decreased −2.259 102
Organismal Development size of body 2.79E-10 Decreased −2.293 193
Table 3. Top 20 diseases and functions associated with the genes in the dataset. Only diseases and functions 
with a predictable activation score (z-score <−2 and >2) and a p value < 0.05 were included.
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Statistical analysis. Statistical analysis of qPCR data was performed with GraphPad InStat® software, with the 
Mann-Whitney U test being used to compare means and the Pearson test to correlate gene expression values with 
degree of degeneration. p-values less than 0.05 were considered significant.
Data availability. The datasets generated during and analysed during the current study are available from 
Array Express (https://www.ebi.ac.uk/arrayexpress/; accession number E-MTAB-6868).
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